Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC.MIRA · Entity 7362 | Director | August 02, 2023 | August 02, 2023 |
| Telomir Pharmaceuticals, Inc.TELO · Entity 6962 | Director | February 08, 2024 | February 08, 2024 |
| Westrock Coffee CoWEST · Entity 5164 | Director | June 05, 2026 | June 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MIRA PHARMACEUTICALS, INC.
Report date August 02, 2023 · Filed August 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2023-08-02 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 40,000 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2032-06-15 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2023-08-02 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F1: The option vested and became exercisable in full on June 15, 2022. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.00 · Expires 2033-04-28 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2023-08-02 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F2: The option vested and became exercisable in full on April 28, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vested and became exercisable in full on June 15, 2022.
F2: The option vested and became exercisable in full on April 28, 2023.
Telomir Pharmaceuticals, Inc.
Report date February 08, 2024 · Filed February 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,781 |
Reported balance
Holding disclosure · report date 2024-02-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 48,781 |
Westrock Coffee Co
Report date June 05, 2026 · Filed June 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMMON STOCKSEC Table I · non-derivative | Direct | 49,009 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Grant · Acquired 10,798 · Balance 49,009 F1: These restricted stock units ("RSUs") are granted pursuant to the Westrock Coffee Company 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the issuer's common stock, par value $0.01 per share. The RSUs will vest on June 5, 2027, subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date and certain early vesting conditions. |
Filing footnotes · ownership attribution and instrument terms
F1: These restricted stock units ("RSUs") are granted pursuant to the Westrock Coffee Company 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the issuer's common stock, par value $0.01 per share. The RSUs will vest on June 5, 2027, subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date and certain early vesting conditions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2026 Filed Jun 8, 2026 20:20 UTC | Westrock Coffee Co WEST · Entity 5164 | GrantCOMMON STOCK | 10,798 | $0.00 | $0.00 |
DisclosureSEC source: 0001934476-26-000001 · primary_doc.xml · nonDerivative · entry 1 McColl Hugh III · CIK 0001934476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,009 F1 · shares: These restricted stock units ("RSUs") are granted pursuant to the Westrock Coffee Company 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the issuer's common stock, par value $0.01 per share. The RSUs will vest on June 5, 2027, subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date and certain early vesting conditions. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:32 UTC | Westrock Coffee Co WEST · Entity 5164 | GrantCOMMON STOCK | 12,471 | $0.00 | $0.00 |
DisclosureSEC source: 0001903601-25-000050 · primary_doc.xml · nonDerivative · entry 1 McColl Hugh III · CIK 0001934476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,211 F1 · shares: These restricted stock units ("RSUs") are granted pursuant to the Westrock Coffee Company 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the issuer's common stock, par value $0.01 per share. The RSUs will vest on June 6, 2026, subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date and certain early vesting conditions. Read SEC document |
| June 06, 2024 Filed Jun 10, 2024 21:26 UTC | Westrock Coffee Co WEST · Entity 5164 | GrantCOMMON STOCK | 8,523 | $0.00 | $0.00 |
DisclosureSEC source: 0002022453-24-000011 · primary_doc.xml · nonDerivative · entry 1 McColl Hugh III · CIK 0001934476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,740 F1 · shares: These restricted stock units ("RSUs") are granted pursuant to the Westrock Coffee Company 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the issuer's common stock, par value $0.01 per share. The RSUs will vest on June 6, 2025, subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date and certain early vesting conditions. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 21:04 UTC | Westrock Coffee Co WEST · Entity 5164 | GrantCOMMON STOCK | 8,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001861394-23-000016 · primary_doc.xml · nonDerivative · entry 1 McColl Hugh III · CIK 0001934476 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,217 F1 · shares: These restricted stock units ("RSUs") are granted pursuant to the Westrock Coffee Company 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the issuer's common stock, par value $0.01 per share. The RSUs will vest on August 14, 2024, subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date and certain early vesting conditions. Read SEC document |
| August 29, 2022 Filed Aug 29, 2022 21:47 UTC | Westrock Coffee Co WEST · Entity 5164 | GrantCOMMON STOCK | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001903601-22-000101 · primary_doc.xml · nonDerivative · entry 1 McColl Hugh III · CIK 0001934476 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 F1 · shares: These restricted stock units ("RSUs") are granted pursuant to the Westrock Coffee Company 2022 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the issuer's common stock, par value $0.01 per share. The RSUs will vest on August 29, 2023, subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date and certain early vesting conditions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.